Jim Cramer on Medtronic: “This Long-Term Winner’s Become a Short-Term Loser”

Medtronic plc (NYSE:MDT) was among the stocks Jim Cramer was focused on, as he discussed Mad Money’s latest game plan for the week. Cramer highlighted the company’s share price performance, as he said:

Wednesday morning, Medtronic reports. Speaking of jarring, this long-term winner’s become a short-term loser with the stock down 23% year to date. Medtronic is not alone; most of the medical device stocks are down with the worst being one of the best just last year, Boston Scientific, almost 50% down. I wish I could be aggressive in recommending Medtronic on Monday morning, but I can’t. Right now, we gotta wait to see the quarter. That group’s so awful.

Stock market data. Photo by Jakub Zerdzicki on Pexels

Medtronic plc (NYSE:MDT) develops and sells device-based medical therapies to healthcare systems, physicians, and patients. The company provides specialized products, including cardiac pacemakers, surgical instruments, robotic-assisted surgery platforms, and a number of diabetes management systems. A caller inquired about the stock during the March 26 episode, and Cramer replied:

I have to tell you, I was surprised that Medtronic got back down to the high $80s. I think that everything they’ve been doing lately is right. I think you’ve got a good one. By the way, it’s 15 times earnings. That’s very inexpensive. I would buy more… I know it sounds like you’re just averaging down into oblivion, but I think it’s a great level.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.